Progress in drug treatment for children with bronchial asthma
10.3760/cma.j.issn.1673-4408.2020.03.001
- VernacularTitle:儿童支气管哮喘治疗药物研究进展
- Author:
Xiaoyang WANG
1
;
Chuanhe LIU
Author Information
1. 首都儿科研究所附属儿童医院变态反应科，北京 100020
- From:
International Journal of Pediatrics
2020;47(3):151-154
- CountryChina
- Language:Chinese
-
Abstract:
Pharmacotherapy is the main part of management of bronchial asthma in children.However, due to the heterogeneity of bronchial asthma, some patients are poorly controlled despite regular medication.Thus new drug and technologies need to be explored.With deep understanding of the pathogenesis of bronchial asthma, a lot of new drugs were available to asthmatic patients, especially the targeted drugs dominated by monoclonal antibodies, which have become the hot spot of bronchial asthma treatment.
